Policy perspectivesChallenges in the Development and Reimbursement of Personalized Medicine—Payer and Manufacturer Perspectives and Implications for Health Economics and Outcomes Research: A Report of the ISPOR Personalized Medicine Special Interest Group
Under an Elsevier user license
open archive
Keywords
diagnostics
health economics and outcomes research
health technology assessment
personalized medicine
reimbursement
Cited by (0)
Copyright © 2012 International Society for Pharmacoeconomics and Outcomes Research (ISPOR). Published by Elsevier Inc. All rights reserved.